This ADC product is composed of an anti-EGFR antibody conjugated via SMCC linker to methotrexate (cetuximab-SMCC-methotrexate). It has demonstrated a response in EGFR-positive cetuximab-resistant cancer cells treatment by a MOA (Mechanism of Action) of counteracting and competing with folic acid in cancer cells resulting in folic acid deficiency in the cells and causing their death .
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1078z | Mouse Anti-EGFR Recombinant Antibody (clone 42C11) | WB, ELISA, FC, IF, IHC, FuncS | Mouse IgG1, κ |
PABL-080 | Human Anti-EGFR Recombinant Antibody (PABL-080) | ELISA, WB, FuncS | Human IgG |
FAMAB-0094YC | Human Anti-EGFR Recombinant Antibody (clone F4) | ELISA, WB, FC | Human IgG |
HPAB-1443LY | Human Anti-EGFR Recombinant Antibody (clone P1X) | ELISA, WB | Human IgG |
HPAB-1444LY | Human Anti-EGFR Recombinant Antibody (clone P2X) | ELISA, WB | Human IgG |
There are currently no Customer reviews or questions for ADC-059LZY. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.